• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epi

tetano

Editor, Senior Moderator
First Published on January 31, 2012, doi: 10.1074/jbc.M111.304758 jbc.M111.304758.

Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damage

Christophe Paget1,
Stoyan Ivanov1,
Josette Fontaine1,
Joelle Renneson1,
Fany Blanc2,
Muriel Pichavant1,
Laure Dumoutier3,
Bernhard Ryffel4,
Jean Christophe Renauld3,
Philippe Gosset5,
Pierre Gosset6,
Mustapha Si-Tahar2,
Christelle Faveeuw5 and
Fran?ois Trottein1,*

+ Author Affiliations

1 Institut Pasteur Lille, France;
2 Institut Pasteur Paris, France;
3 Ludwig Institute, Belgium;
4 CNRS, France;
5 Institut Pasteur lille, France;
6 Hopital Saint Vincent, France

↵* Corresponding author; email: francois.trottein@pasteur-lille.fr

Capsule

Background: Invariant natural killer T (iNKT) cells play a beneficial role during influenza A virus (IAV) infection

Results: iNKT cells produce IL-22 during infection and IL-22 prevents the IAV-triggered cell death of pulmonary epithelium

Conclusion: IL-22 produced by iNKT cells might be important during IAV infection

Significance: Understanding how iNKT cells function during IAV infection might be instrumental to control IAV-associated pathogenesis
Abstract

Invariant natural killer T (iNKT) cells are non-conventional lipid-reactive ab T lymphocytes that play a key role in host responses during viral infections, in particular through the swift production of cytokines. Their beneficial role during experimental influenza A virus (IAV) infection has recently been proposed, although the mechanisms involved remain elusive. Here, we show that during in vivo IAV infection, mouse pulmonary iNKT cells produce IFN-g and IL-22, a Th17-related cytokine critical in mucosal immunity. Although permissive to viral replication, IL-22 production by iNKT cells is not due to IAV infection per se of these cells but is indirectly mediated by IAV-infected dendritic cells (DCs). We show that activation of the viral RNA sensors TLR7 and RIG-I in DCs is important for triggering IL-22 secretion by iNKT cells whilst the NOD-like receptors NOD2 and NLRP3 are dispensable. Invariant NKT cells respond to IL-1b and IL-23 provided by infected DCs, independently of the CD1d molecule, to release IL-22. In vitro, IL-22 protects IAV-infected airway epithelial cells against mortality but has no role on viral replication. Finally, during early IAV infection, IL-22 plays a positive role in the control of lung epithelial damages. Overall, IAV infection of DCs activates iNKT cells providing a rapid source of IL-22 that might be beneficial to preserve the lung epithelium integrity.


http://www.jbc.org/content/early/2012/01/31/jbc.M111.304758.abstract
 
Back
Top Bottom